VPAG Investment Fund

Market Access

Under the VPAG agreement, £400 million is available under the VPAG Investment Fund. But what benefits will stay once funding goes away in 2029?

News

Johnson & Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.